In the huge expanse of Asia, Singapore and
|
|
- Dorothy Sanders
- 6 years ago
- Views:
Transcription
1 New Medical Device Regulation 16 February 2009
2 By Ames Gross In the huge expanse of Asia, Singapore and Hong Kong are small places. However, after Japan, they are among the most advanced medical markets in the region. They also lead other nearby, much larger Asian markets: Singapore strongly influences the Association of Southeast Asian Nations (ASEAN) and Hong Kong strongly influences China. While these two markets have had little medical device regulation in the past, they are both introducing new requirements. Singapore Overview Singapore is the wealthiest, most developed member of ASEAN, with a gross domestic product, or GDP (based upon purchasing power parity (PPP)), of $228 billion (US) in The Singaporean population was about 4.6 million in 2008, up from about 4 million in In contrast, Taiwan s population is four times Singapore s while its GDP is only three times Singapore s. Among Asian nations, Singapore s estimated 2007 GDP per capita (PPP), almost $50,000, is second only to Brunei s. The medical device market in Singapore stood at $178 million in 2006 and is estimated to reach $276 million by With its dependence upon imports, strong economy and aging population, Singapore will continue to draw Western companies. While Singapore now has a voluntary regulatory environment, new regulations being implemented will require registering all medical devices by Regulatory Authority Singapore s chief medical regulatory body is the Health Sciences Authority (HSA), founded in April Following a restructuring in August 2008, it now comprises three professional groups that oversee the three major functions of the HSA: The Health Products Regulation Group regulates drugs, medical devices, etc. It includes the Center for Medical Device Registration (CMDR), which conducts safety registration, certification and s in Singapore and Hong Kong Regulatory Focus 17
3 inspection for medical devices. The Applied Sciences Group provides forensic medical and scientific expertise to assist in public health and justice issues. The Blood Services Group oversees Singapore s blood supply. Singapore has had a voluntary medical device registration system in place since 2002, but HSA recently implemented a plan for standardizing and regulating medical devices. While the phases of the plan have been scheduled for implementation in specific years, this schedule may shift in the future. In 2007, the Health Products Act was passed, allowing HSA to conduct mandatory product registration and regulate the supply, distribution, manufacturing, import and advertisement of health products. Shortly afterward, phase 1 of HSA s implementation plan began, requiring device firms to report product defects and adverse events to the authority. Companies are also required to notify HSA before initiating a product recall. Additionally, false or misleading advertisements of medical devices are prohibited. Beginning in the fourth quarter of 2008, in phase 2, HSA will begin to license parties dealing in medical devices, including manufacturers and distributors. To prepare for this requirement, product registration applications will be accepted for all medical devices. In the second quarter of 2010, phase 3 will prohibit unlicensed parties from manufacturing, importing or wholesaling medical devices. It will also prohibit the sale of unregistered Class B, C and D medical devices (see details of Singapore s classification system below). In the second quarter of 2011, the sale of unregistered Class A medical devices will also be prohibited. Thus, by the second quarter of 2011, all medical devices will need to be registered in Singapore, and all dealers, including manufacturers and distributors, will need to be licensed with HSA. Medical Device Classification Medical devices are classified in Singapore based upon the risk associated with their intended purpose. The product s owner is responsible for determining the risk classification, which the registrant (defined below) verifies upon product registration. HSA will make an initial review to determine whether the device has been correctly classified. However, it is not clear what the authority will do if the classification is incorrect, whether it will reject the application or change the classification itself. The following factors influence device classification: how long the device is in contact with the body; the device s invasiveness; whether the device delivers medicinal products or energy to the patient; whether the device is intended to have a biological effect on the patient; and whether the device has local or systemic effects on the body. There are four risk classifications of medical devices in Singapore: Class A, low risk; Class B and C, medium risk; and Class D, high risk. Of the 400,000 types of medical devices in Singapore, 60% are Class A, e.g., surgical retractors and tongue depressors; 30% are Class B and C, e.g., hypodermic needles and lung ventilators; and 10% are Class D, e.g., heart valves or implantable defibrillators. Product Registration Registered devices are listed on the Singapore Medical Device Register (SMDR), which is publicly available online ( hsaportal/en/services/medics/smdr.html). Annual renewal of product registration is required as the listing expires each year on 30 September. Renewal notices are sent to the registrant on a yearly basis. Under Singaporean standards, the registrant is defined as the party that applies for and obtains product registration for a medical device on behalf of the manufacturer. This must be a Singaporean company registered with the Accounting and Corporate Regulatory Authority (ACRA). The registrant acts as the main contact person for HSA, and must register with the authority in order to use the online Medical Device Information and Communication System (MEDICS) to submit product registration applications. The product owner is defined as the manufacturer, or the party who named the device, and must issue a Letter of Authorization to the registrant for each product registration application submitted. Before a device dossier or product registration application is submitted, HSA must initially verify that the product qualifies as a medical device under the Health Products Act. Once it is confirmed to be a medical device, the application process can begin. If there are specific issues with the dossier or application, the registrant can request a presubmission consultation session with HSA. A dossier should be submitted to HSA one month before the consultation process so the authority can review it before advising the registrant. To register a Class A medical device, submission of a full dossier for review will not be 18 February 2009
4 required. Companies registering Class A devices will only need to submit the product registration application to be listed on the SMDR. HSA will simply review the application to determine whether the device is correctly classified and whether the design is appropriate for the intended use. After verifying the risk classification and the product claims, HSA will list the medical device on the SMDR. Product owners of Class A devices also will have a legal obligation to keep complete distribution and complaint records, as well as notify HSA of product recalls and adverse events. Companies registering Class B, C and D medical devices must submit a device dossier in the Common Submission Dossier Template (CSDT) format online via MEDICS. The CSDT format will be used in all 10 ASEAN countries by 2015, meaning that a dossier accepted by HSA in Singapore can also be accepted in the same format by all ASEAN regulatory authorities. A dossier in CSDT format must be prepared in English and approved by the product owner. It must include clinical evidence and clearly identified labeling, technical descriptions and instructions. Copies of all labeling, certificates and reports referenced within the CSDT must be attached. After a dossier is submitted, HSA will initially screen it for correct classification, format and completeness. If HSA raises any issues during this process, the registrant must reply within 30 days. Once those issues are clarified, the dossier will be accepted for full review. HSA s evaluation of accepted dossiers normally takes 60 days. If the registrant does not meet the deadline for clarifying issues, the dossier will be rejected. If HSA approves the device dossier, the registrant will then be able to submit a product registration application for listing on the SMDR. Companies with Class B, C and D devices that already have market approval from the founding members of the Global Harmonization Task Force (GHTF), i.e., Australia, Canada, the EU, Japan and the US, may make an abridged submission. Although the required content is the same, the review process is simpler. All technical documentation, including packaging, labeling, instructions for use and indications for use, which were approved by a GHTF country, can be submitted for product registration in Singapore. The registrant must notify HSA if there are any changes to the information given in the application for Class B, C and D medical devices. If significant changes are made to the medical device, HSA must give approval before the changed device can be sold in Singapore. Hong Kong Overview On a per-capita basis, Hong Kong is the thirdwealthiest country in Asia after Singapore and Brunei. Hong Kong has a population of 6.9 million and had a $293 billion GDP (PPP) in In comparison, Belgium has a population of about 10.7 million, and had a GDP (PPP) of $377 billion in Although now a part of China, as a special administrative region Hong Kong has its own medical device regulations separate from China s. Having only a few local device manufacturers, Hong Kong imports most of its medical devices. While there has been little legislative control over the import process in the past, recent changes to Hong Kong s medical device registration system suggest that requirements for medical devices will be more strict in the future. Regulatory Focus 19
5 Regulatory Authority The Department of Health (DOH) is the main health authority in Hong Kong. Under DOH, the Medical Device Control Office (MDCO) regulates medical devices. Established in 2004, MDCO consists of the Medical Device Registration Section and the Post-Marketing Surveillance Section. On 26 November 2004, DOH launched the Medical Device Administrative Control System (MDACS) as a regulatory framework for imported medical devices. The standards in MDACS are adopted from the GHTF recommendations for medical devices. While the MDACS listing system is currently voluntary, it is intended to familiarize manufacturers and distributors with mandatory requirements that are in development. In November 2004, phase 1 of MDACS was implemented to start a listing of high-risk (Class IV) medical devices that meet MDACS standards for safety and quality. The listing includes the device s make and model, manufacturer contact details, and contact details for the Local Representative Person (LRP). This list is available to the public on the MDCO website (www. mdco.gov.hk). In November 2005, phase 2 expanded the listing to include medium-risk (Class II and III) medical devices. In October 2006, phase 3 began the Conformity Assessment Body Recognition Scheme. In this phase, MDCO began to recognize Conformity Assessment Bodies (CABs) that can perform conformity assessment showing that a device has fulfilled MDACS requirements. In March 2007, phase 4 began the listing of local manufacturers. Requirements for manufacturers include ISO certification and adequate Quality Management Systems (QMS). In July 2007, phase 5 began the listing of medical device importers. Requirements for importers include keeping complete distribution records and having appropriate procedures for product recall and adverse event assessment. Despite the lack of legislative control over the import of medical devices, MDCO can still intervene if it feels a marketed device is unsafe or unfair to the Hong Kong population. In these cases, the device is not taken off the market, but MDCO can write a letter to hospital authorities advising hospitals and doctors not to purchase it. Medical Device Classification Medical devices in Hong Kong are classified according to the risk level associated with their intended use. Class I devices are low-risk, e.g., bandages and dressings. Class II devices are medium-low-risk, e.g., suction pumps and gastroscopes. Class III devices are medium-high-risk, e.g., orthopedic implants and medical lasers. Class IV devices are high-risk, e.g., prosthetic heart valves and implantable cardiac pacemakers. MDCO has adopted the GHTF definition of medical device. Some medical devices that fall under this definition, however, still remain outside the current scope of MDACS. MDCO is currently developing a plan to regulate them. These products include: devices that incorporate human blood, plasma and blood cells, excluding stable derivative devices; products incorporating or derived from transplants, tissues or cells of human or animal origin, excluding products with nonviable animal tissue; in vitro diagnostic (IVD) medical devices; and substances or devices placed in contact with external parts of the body or the oral cavity to clean or improve them for cosmetic purposes. Product Registration The main contact point with MDCO is the LRP, which must be a locally registered entity. The LRP must be either the device manufacturer or an entity approved by the manufacturer to perform the duties of the LRP. The LRP submits the application for listing medical devices and fulfills any requests from MDCO, e.g., making documents referenced in the application available for inspection. After the device is listed, the LRP is responsible for marketing and postmarket procedures, which include keeping distribution records, handling complaints, initiating product recalls, managing adverse incidents and reporting changes. The manufacturer must issue an LRP appointment letter and attach it to each product registration application. Currently, market approval from one of the GHTF founding members (the US, Canada, Australia, the EU and Japan) is required for medical device registration in Hong Kong. Evidence of approval must be attached to the product registration application. Applicants must also attach the Essential Principles Conformity Checklist (MD-CCL) to the product registration application to demonstrate that the device complies with MDACS requirements. This checklist is not exactly the same as the Essential Requirements Checklist of the EU Medical Device Directives, but it is similar. Therefore, if the applicant already has a checklist that was part of a prior EU approval, that document may be submitted instead with a declaration that the checklist also satisfies MD-CCL 20 February 2009
6 requirements. Medical devices that received market approval from a GHTF founding member on or before 31 December 2004, however, are exempt from submitting an MD-CCL. The completed application form must be submitted with all supporting documents and labeling samples attached. The average evaluation period is about 12 weeks, though this can vary. After evaluation, the application will be rejected, approved or conditionally approved. Conditional approvals will specify conditions to be met, such as requiring specific postmarket surveillance studies. It is possible to appeal rejections or conditional approvals by writing to the secretary of the Medical Device Administration Appeal Committee. A major component of an application is conformity assessment. Conformity assessment covers a product s quality management system, postmarket surveillance system, Summary Technical Documentation (STED) and Declaration of Conformity, all based upon MDACS standards. Conformity assessment will be performed not by MDCO but by a CAB. All CABs must be certified by MDCO. CABs will have some discretion to simplify or enhance the conformity assessment requirements depending upon their experience with a product or its specific characteristics. In general, Class II devices will not need to have an STED submitted as part of quality assessment, although they still will be subject to the other requirements listed above. CABs will need to review the STEDs for Class III and IV devices routinely. Currently, the Hong Kong government does not plan to charge a fee for the listing of medical devices. However, CABs will charge fees to conduct conformity assessments. Even after receiving approval, a medical device may be permanently or temporarily delisted at the discretion of MDCO. This can happen for many reasons, which include jeopardizing public health or safety, failing to comply with MDACS requirements or failing to adequately address a hazard. Author Ames Gross is president and founder of Pacific Bridge Medical. He helps medical companies with business development and regulatory issues in Asia. For more information on Pacific Bridge Medical, please visit our website at Regulatory Focus 21
Regulation of Medical Devices in Hong Kong. Dr Terence CHEUNG Principal Medical and Health Officer Department of Health, Hong Kong SAR
Regulation of Medical Devices in Hong Kong Dr Terence CHEUNG Principal Medical and Health Officer Department of Health, Hong Kong SAR 1 Content Background Latest Legislative Development Medical Device
More informationMEDICAL DEVICE GUIDANCE
Effective from 1 January 2013 MEDICAL DEVICE GUIDANCE GN-15: Guidance on Medical Device Product Registration Revision 5 CONTENTS 1. INTRODUCTION... 4 1.1. Scope... 5 1.2. Definitions... 5 2. RISK CLASSIFICATION
More informationPrinciples of Conformity Assessment for Medical Devices
Technical Reference: TR-001 Date of Issue: 13 Oct. 2006 Principles of Assessment for Medical Devices Technical Reference: TR-001 Department of Health The G overnment of the Hong K ong S pec ial Adminis
More informationUPDATES ON THE ASEAN MEMBER STATES. Washington, September 2014
UPDATES ON THE ASEAN MEMBER STATES Washington, September 2014 WHERE WILL BE THE ASEAN COMMUNITY MEDICAL DEVICE SECTOR BY 2020? HOW IS IT GOING TO GIVE A BUSINESS IMPACT IN THE MEDICAL DEVICE SECTOR? Facts
More informationOverview of Regulatory Framework for Medical Devices & IVDs and likely Implementation Roadmap. Jane Rogers SAAPI Conference 13 April 2016
Overview of Regulatory Framework for Medical Devices & IVDs and likely Implementation Roadmap Jane Rogers SAAPI Conference 13 April 2016 Regulatory Framework for Medical Devices & IVDs HAZARDOUS SUBSTANCES
More informationFINAL DOCUMENT. Global Harmonization Task Force. Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices
GHTF/SG1/N046:2008 FINAL DOCUMENT Global Harmonization Task Force Title: Principles of Assessment for In Vitro Diagnostic (IVD) Medical Devices Authoring Group: Study Group 1 of the Global Harmonization
More informationFirst Global Forum on Medical Devices Bangkok-Thailand, September Regulatory Control of Medical Devices in Tanzania
First Global Forum on Medical Devices Bangkok-Thailand, September 9-11 2010 Regulatory Control of Medical Devices in Tanzania Mr. Hiiti Sillo Ag. Director General Tanzania Food and Drugs Authority hiiti@yahoo.com/hiiti.sillo@tfda.or.tz
More informationPROPOSED DOCUMENT. Global Harmonization Task Force. Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices
SG1(PD)/N046R3 PROPOSED DOCUMENT Global Harmonization Task Force Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices Authoring Group: Study Group 1 of the Global Harmonization
More informationThe European Commission proposes new rules for medical devices
for medical devices On 26 September 2012 the European ( ) presented its proposal to the European Parliament and the Council regarding two new regulations on medical devices. The Parliament and the Council
More informationSurvey on Legal Measures Mechanism on Medical Devices
Survey on Legal Measures Mechanism on Medical Devices The Working Group on Medical Measurements The 24rd Forum Meeting SIEM REAP, CAMBODIA Oct. 25-27, 2017 Hui-Ling Ting Bureau of Standards, Metrology
More informationMedical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS
Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,
More informationContents. Regulatory Bodies... 13
Contents UNITED STATES... 3 Regulatory Bodies... 3 Product Classification and Regulatory Control... 3 Application Documents... 3 Quality System Requirements... 4 Product and Manufacturer s License... 4
More informationCourse Title ID Duration Basic Premium. Biological Evaluation of Medical Devices: A Risk-Based Approach N mins
Pre-Clinical Basic Level : CMDA Certified Medical Device Associate Biological Evaluation of Medical Devices: A Risk-Based Approach N134 63 mins 186.00 144.00 Introduction to Process Validation N135 75
More informationHealthcare Quality Requirements
Healthcare Quality Requirements 1 Regional Healthcare Regulatory Agencies Country Local Regulatory Agency Singapore Health Sciences Authority Thailand Thailand Food and Drug Administration (TFDA) Medical
More informationMedtech: Global Regulatory Strategy in Medical Device Product Development
Medtech: Global Regulatory Strategy in Medical Device Product Development We contribute to healthcare For Medical Device & Drug May Ng Director, Regulatory & Quality Consultant may.ng@arq-on.com Disclaimer:
More informationComparative Overview of Other Medical Devices Regulatory Systems
Comparative Overview of Other Medical Devices Regulatory Systems Dr David Jefferys, BSc MD, FRCP, FFPM Medical Device Expert Senior Vice President Global Regulatory, Healthcare Policy and Corporate Affairs
More informationTips to Taiwan Medical Device Regulation
Tips to Taiwan Medical Device Regulation 15 th March, 2017 Rachel Tserng Qualification in Biotechnology and Business Bilingual in English and Mandarin Experience in preparation and management of regulatory
More informationAn introductory guide to the medical device regulation (MDR) and the in vitro diagnostic medical device regulation (IVDR)
An introductory guide to the medical device regulation (MDR) and the in vitro diagnostic medical device regulation (IVDR) devices.implementation@mhra.gov.uk 1 Introduction - How to use this guide Navigate
More informationYour Vision, Our Future Korean Medical Device Your Vision, Our Future
www.mfds.go.kr/eng Your Vision, Our Future Korean Korean Your Vision, Our Future 01 Passion for Growth & Excellence With a 5% average annual growth rate, the Korean medical device market was valued at
More informationMedical Device Regulatory Roadmap SAMED Conference 2-3 December 2015
Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Dr J. Gouws Registrar of Medicines Status in RSA: 2 December 2015 Legislation: Bill 6D, 2014 Defines MD and IVDs Licensing of Manufacturers,
More informationGuide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland
Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland AUT-G0095-1 15 AUGUST 2014 This guide does not purport to be an interpretation of law and/or regulations and is for
More informationMDS - G4 GUIDANCE FOR OVERSEAS MANUFACTURERS
MDS - G4 GUIDANCE FOR OVERSEAS MANUFACTURERS Part I: Preparing for Medical Device Part II: Applying for Medical Device Marketing Authorization Part III: Activities after the Device Receives Marketing Authorization
More informationKorean Medical Devices Regulations
Korean Devices Regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall responsibility for Devices. The Korea Food and Drug Administration (MFDS), an agency under MHW,
More informationRegulatory Updates Health Sciences Authority Singapore
Regulatory Updates Health Sciences Authority Singapore September 2018 Wong Woei Jiuang Ag Asst Group Director, Medical Devices Cluster, Health Sciences Authority, Singapore Key Regulatory Changes 1. Regulatory
More informationMEDICAL DEVICES SECTOR
MEDICAL DEVICES SECTOR MDS - G4 GUIDANCE FOR OVERSEAS Version 2 Our mission is to ensure the safety of food. the safety, quality and efficacy of drugs. and the safety and effectiveness of medical devices,
More informationMedical Device Regulatory Roadmap SAMED Conference 2-3 December 2015
Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Dr J. Gouws Registrar of Medicines Overview Global status on MD and IVDs National status on MD and IVDs Legislation Key player and Responsibilities
More informationRegulatory Framework for Medical Device
Regulatory Framework for Medical Device International Seminar Safety of Health Products French Ministry of Labour, Employment and Health Paris, 26 May 2011 Peter Bischoff-Everding European Commission EU
More informationUNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD)
UNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD) A. Background January 2019 UNICEF Technical requirements for Medical Devices are the requirements that suppliers need to comply with, and that products
More informationMEDICINES CONTROL COUNCIL
Licence to act as a Wholesaler or Distributor MEDICINES CONTROL COUNCIL GUIDELINES FOR LICENCE TO ACT AS A WHOLESALER or DISTRIBUTOR This guideline is intended to provide recommendations to applicants
More informationCOMMISSION RECOMMENDATION. of XXX. on the audits and assessments performed by notified bodies in the field of medical devices
EUROPEAN COMMISSION Brussels, XXX [ ](2013) XXX draft COMMISSION RECOMMENDATION of XXX on the audits and assessments performed by notified bodies in the field of medical devices (Text with EEA relevance)
More informationOVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS
D i a g n o s t i c s a n d L a b o r a t o r y T e c h n o l o g y OVERVIEW OF THE PREQUALIFICATION OF MALE CIRCUMCISION DEVICES ASSESSMENT PROCESS Prequalification of Male Circumcision Devices PQMC_007
More informationHOW TO APPLY FOR MEDICAL DEVICE REGISTRATION UNDER MEDICAL DEVICE ACT 2012 (ACT 737)
MDA/GL No 1: July 2013 Guidelines for implementation of medical device regulatory system HOW TO APPLY FOR MEDICAL DEVICE REGISTRATION UNDER MEDICAL DEVICE ACT 2012 (ACT 737) [Appendix 4 Schedule 3 Medical
More informationDRUG DRAFT GUIDELINE FOR REGISTRATION OF MEDICAL DEVICES FOR HUMAN USE IN UGANDA, SEPTEMBER 2009
DRUG NATIONAL AUTHORITY DRAFT GUIDELINE FOR REGISTRATION OF MEDICAL DEVICES FOR HUMAN USE IN UGANDA, SEPTEMBER 2009 TABLE OF CONTENTS: 1 INTRODUCTION 2 DEFINITION OF MEDICAL DEVICE 3 SCOPE OF THE GUIDELINE
More informationMEDICAL DEVICE REGULATION AND ITS COMPARISON IN EUROPE, AUSTRALIA AND INDIA
Page1211 Indo American Journal of Pharmaceutical Research, 2015 ISSN NO: 2231-6876 MEDICAL DEVICE REGULATION AND ITS COMPARISON IN EUROPE, AUSTRALIA AND INDIA Pooja Brijeshkumar Patel, Ms. Krupa Chaitanyakumar
More informationRegulatory Requirements for Registration of Generic Products in Singapore & Thailand
ISSN 2395-3411 Available online at www.ijpacr.com 651 Review Article Regulatory Requirements for Registration of Generic Products in Singapore & Thailand Sripathi Bhavya sri Department of Pharmaceutical
More informationMedical Device Regulatory Framework
Medical Device Regulatory Framework 24 July 2015 SAMED Member Meeting Contents 1. Context 2. Regulatory framework Key concepts Process 3. Changes 4. What to do? 1. Context Act 101 of 1965 as amended Draft
More informationREGULATIONS OF REGISTRATION AND IMPORT OF MEDICAL DEVICE IN INDIA
REGULATIONS OF REGISTRATION AND IMPORT OF MEDICAL DEVICE IN INDIA Available online at www.ijdra.com REVIEW ARTICLE 1 Budhwaar Vikaas *, 1 Rohilla Yogesh, 2 Choudhary Manjusha, 3 Prateek kumar 1 Department
More informationCOPING WITH INCREASING NEEDS FOR INSPECTIONS: ASEAN INITIATIVES. Abida Syed M Haq Ministry of Health, Malaysia
COPING WITH INCREASING NEEDS FOR INSPECTIONS: ASEAN INITIATIVES Abida Syed M Haq Ministry of Health, Malaysia Presentation Outline About ASEAN Background Economic Integration Current Scenario Acceptable
More informationMedical Device Registration in China
www.cirs-md.com IVD Medical Device Registration in China Your Local Regulatory Affairs Staff-CIRS CIRS assist you Overseas Medical Devices In Vitro Diagnostic reagent Market access CFDA Registration Pre-market
More informationGuide to the in-vitro diagnostic medical devices legislation
Guide to the in-vitro diagnostic medical devices legislation Item Type Other Authors Irish Medicines Board (IMB) Publisher Irish Medicines Board (IMB) Download date 17/10/2018 04:46:25 Link to Item http://hdl.handle.net/10147/97003
More informationStaffing - Medical Devices
Staffing - Medical Devices LONDON GENEVA SINGAPORE DUBLIN procorre.com 1 Implementing solutions to clients worldwide 2 Contents Services 04 Sector Overview 07 Medical Devices 07 In-Vitro Diagnostics 08
More informationMEDICAL DEVICE. Technical file.
MEDICAL DEVICE Technical file www.icaro-research.eu ICARO MDTF v1.0 1 Mar 2016 1. Do you plan to launch your medical device in Europe? If you re reading this, chances are good that you re considering introducing
More informationDiagnostics new product development: overview, WHO s scientific and regulatory role, regulatory pathways and demand creation
Diagnostics new product development: overview, WHO s scientific and regulatory role, regulatory pathways and demand creation Irena Prat Technical Officer, PQDx 1 Global Dx regulatory landscape Dx regulation
More informationApplication of ISO/IEC 17011:2004 in the Field of Medical Device Quality Management Systems (ISO 13485)
IAF Mandatory Document Application of ISO/IEC 17011:2004 in the Field of Medical Device Quality Management Systems (ISO 13485) Issue 3 (IAF MD 8:2017) Issued: 09 June 2017 Application Date: 09 June 2018
More informationAMI MQP Market & Regulatory Analysis. Kyle Cayabyab Jameel Galloway Matt Hammond Meagan Ward
AMI MQP Market & Regulatory Analysis Kyle Cayabyab Jameel Galloway Matt Hammond Meagan Ward Overview Percentage PERCENT ARRHYTHMIA CASES THAT ARE AF 70 60 50 40 30 20 10 0 Percent Arrhythmia Cases that
More informationREGISTRATION OF MEDICAL DEVICE. SUBMISSION & APPLICATION By IDAMAZURA IDRIS MEDICAL DEVICE AUTHORITY
REGISTRATION OF MEDICAL DEVICE SUBMISSION & APPLICATION By IDAMAZURA IDRIS MEDICAL DEVICE AUTHORITY Medical device: regulated item under the Medical Device Act 2012 (Act 737) and its regulation The objective:
More informationTHE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES
THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES Agnette de Perio Peralta and Maria Cecilia Credo Matienzo (apperalta@co.doh.gov.ph and mccmatienzo@yahoo.com) Center for Device
More informationMedical Devices. LATVIA LAWIN Klavins & Slaidins
Medical Devices LATVIA LAWIN Klavins & Slaidins CONTACT INFORMATION Sarmis Spilbergs LAWIN Klavins & Slaidins Elizabetes 15, Riga, LV 1010, Latvia +371 67814848 sarmis.spilbergs@lawin.lv www.lawin.com
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL LICENCE APPLICATION TO ACT AS WHOLESALER of MEDICAL DEVICES and IVDs An application form for the purpose of obtaining a licence or renewing an existing licence in terms of the
More informationRegulatory Framework in Japan - Past and Future - Building a Regulatory Framework Essential Elements of Compliance / Surveillance
Regulatory Framework in Japan - Past and Future - Building a Regulatory Framework Essential Elements of Compliance / Surveillance Nobuo UEMURA Director Office of Medical Devices III Pharmaceuticals and
More informationMEDICAL DEVICE GUIDANCE
June 2018 MEDICAL DEVICE GUIDANCE GN-02: Guidance on Licensing of Manufacturers, Importers and Wholesalers of Medical Devices Revision 4 CONTENTS 1. INTRODUCTION... 4 1.1. Purpose... 4 1.2. Background...
More informationPrequalification of in vitro diagnostics - Technical Update 24 November 2015
Prequalification of in vitro diagnostics - Technical Update 24 November 2015 Copenhagen, Denmark 22-26 November 2015 1 Changes assessment Copenhagen, Denmark 22-26 November 2015 2 Changes to a Prequalified
More informationCOUNTRY OVERVIEW: THAILAND. August 2012 SPECIAL REPRINT. By Rarana Phanudulkitti
August 2012 SPECIAL REPRINT COUNTRY OVERVIEW: THAILAND By Rarana Phanudulkitti Reproduced with the kind permission of Global Regulatory Press from the Journal of Medical Device Regulation, 2012, 9(3),
More informationMedical Device Regulation Overview
Medical Device Regulation Overview Dr Haidong Liang, PhD Clifton Medtech Consulting info@cliftonmedtech.com http://cliftonmedtech.com/ What is the issue? Existing EU Directives dating back to the 1990s
More informationA STUDY ON VARIATIONS IN PHARMACEUTICAL PRODUCTS IN PHILIPPINES AND VARITAION POLICIES IN US, CANADA, AUSTRALIA
ISSN: 2230-7346 Jignesh Shah et al. / JGTPS / 6(1)-(2015) 2340 2344 (Review Article) Journal of Global Trends in Pharmaceutical Sciences Journal home page: www.jgtps.com A STUDY ON VARIATIONS IN PHARMACEUTICAL
More informationManufacturers. Factsheet for. of Medical Devices. Medical Devices Regulation (MDR) background. Act now to be ready on time!
Ref. Ares(2018)3873669-20/07/2018 Factsheet for Manufacturers of Medical Devices This Factsheet is aimed at manufacturers of medical devices. For a general overview of the impact of the In-Vitro Medical
More informationDue diligence in the European medical devices industry
Due diligence in the European medical devices industry Alison Dennis, Reed Smith LLP www.practicallaw.com/0-205-5707 As the medical devices industry is highly regulated, determining a target company's
More informationMedTech Europe Position Paper on Article 50 Negotiations between the European Union and the United Kingdom (Brexit)
MedTech Europe Position Paper on Article 50 Negotiations between the European Union and the United Kingdom (Brexit) EXECUTIVE SUMMARY MedTech Europe the European trade association representing the medical
More informationABRIDGED PREQUALIFICATION ASSESSMENT. Prequalification of In Vitro Diagnostics
P r e q u a l i f i c a t i o n T e a m - D i a g n o s t i c s ABRIDGED PREQUALIFICATION ASSESSMENT Prequalification of In Vitro Diagnostics PQDx_173 v3 12 September 2017 (This document version supersedes
More informationDocument issued on: March 19, The draft of this document was issued on May 20, 2010.
Reprinted from FDA s website by Guidance for Industry, Third Parties and Food and Drug Administration Staff Medical Device ISO 13485:2003 Voluntary Audit Report Submission Pilot Program Document issued
More informationManufacturers. Factsheet for. of Medical Devices. Medical Devices Regulation (MDR) background. Act now to be ready on time!
European Commission Factsheet for Manufacturers of Medical Devices This Factsheet is aimed at manufacturers of medical devices. For a general overview of the impact of the In Vitro Medical Devices Regulation
More informationPerspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules
Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules Planning for Efficiencies of Data, Resources, and Timelines A PRECISION BRIEF Introduction
More informationStandard and Directives on Medical Devices
Standard and Directives on Medical Devices Definition A Medical Device is identified by means of its INTENDED PURPOSE Intended to treat, prevent or control physiological characteristics of a living being
More informationCSA Group Products, Processes and Services Scheme
1. CONTACT CSA CSA Group Products, Processes and Services Scheme 1.1 Getting started is easy. There are three ways to contact us: Call 866 797 4272 Email client.services@csagroup.org Complete a request
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 3. Regulatory fundamentals. Michael Maier
Nano-Tera.ch 05 February 2015 part 3 Regulatory fundamentals Michael Maier michael.maier@medidee.com www.medidee.com Regulatory Fundamentals Medical Devices EU Regulatory System Conformity Assessment US
More informationSelf-Care Medical Devices Framework. Dr. Simone Breitkopf Head HEOR, Governmental and Public Affairs
Self-Care Medical Devices Framework Dr. Simone Breitkopf Head HEOR, Governmental and Public Affairs Disclaimer The view and opinions expressed in the following PowerPoint slides are those of the individual
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL GUIDELINE FOR A LICENCE TO MANUFACTURE, IMPORT, EXPORT OR DISTRIBUTE MEDICAL DEVICES & IVDs This guideline is intended to provide recommendations to applicants wishing to submit
More informationGuidance Document. RMP Template for Farm Dairies Export Eligible Milk. 11 December 2015
Guidance Document RMP Template for Farm Dairies Export Eligible Milk 11 December 2015 A guidance document issued by the Ministry for Primary Industries Title Guidance Document: RMP Template for Farm Dairies
More informationGENERAL AND ORGANISATIONAL REQUIREMENTS
NBOG working document applicable for MDR and IVDR WD 2017-1 Draft list of documents to be submitted in the application for designation as a notified body under Regulation (EU) 2017/745 and Regulation (EU)
More informationManufacturers of in vitro Diagnostic
European Commission Factsheet for Manufacturers of in vitro Diagnostic Medical Devices This Factsheet is aimed at manufacturers of in vitro diagnostic medical devices. For information on the impact of
More informationQuality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines
Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 8. PMA, 510k, IDE. Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 8 PMA, 510k, IDE Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 USA/FDA Pre Market Approval System - PMA, Pre Market Notifcation
More informationPublic Consultation on Annual Review and Proposal for Fees For Financial Year Medical Devices
Public Consultation on Annual Review and Proposal for Fees For Financial Year 2018 Medical Devices 8th May 2018 CONTENTS 1 INTRODUCTION 3 2 REVIEW OF THE 2017 FEES 3 2.1 The 2017 fees 3 2.2 The 2018 fees
More informationINTERNATIONAL CONFORMITY CERTIFICATION PROGRAM
KINGDOM OF SAUDI ARABIA INTERNATIONAL CONFORMITY CERTIFICATION PROGRAM COMPREHENSIVE PROCEDURES and GUIDELINES INTERNATIONAL CONFORMITY CERTIFICATION PROGRAM COMPREHENSIVE PROCEDURES AND GUIDELINES November
More informationPROPOSED DOCUMENT. Playbook for Implementation of a Medical Device Regulatory Framework. Authoring Group: AHWP TECHNICAL COMMITTEE (TC) OFFICE BEARERS
AHWPTC/OB/P001:2014 PROPOSED DOCUMENT Title: Playbook for Implementation of a Medical Device Regulatory Framework Authoring Group: AHWP TECHNICAL COMMITTEE (TC) OFFICE BEARERS Date: August 5 th, 2014 This
More informationAsia Medical Markets Overview February 10, 2015
Asia Medical Markets Overview February 10, 2015 Presented by Ames Gross, President Pacific Bridge Medical 7315 Wisconsin Avenue, Suite 609E, Bethesda, MD 20814. All rights reserved. This content is protected
More informationManufacturers of In-Vitro Diagnostic
Ref. Ares(2018)3873780-20/07/2018 Factsheet for Manufacturers of In-Vitro Diagnostic Medical Devices This Factsheet is aimed at manufacturers of in-vitro diagnostic medical devices. For information on
More informationIVD Regulation Update
IVD Regulation Update BSI Annual Roadshow October 2016 1 IVDR Overview - Update 2 Classification & Conformity Assessment Medical Devices Coordination Group (MDCG) Electronic systems (Eudamed) Summary of
More informationThe Medical Device Coordination Group: a new Authority Under EU Device Regulations
The Medical Device Coordination Group: a new Authority Under EU Device Regulations By Robert D. Cumming and Nancy W. Mathewson, Esq. This article discusses the organization and functions of the Medical
More informationPROPOSED DOCUMENT. Asian Harmonization Working Party Strategic Framework Towards "The Foreseeable Harmonization Horizon"
PROPOSED DOCUMENT Title: Asian Harmonization Working Party Strategic Framework Towards 2020 - "The Foreseeable Harmonization Horizon" Authoring Group: AHWP OFFICE BEARERS Date: September 20 th, 2012 This
More informationReview of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices
Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices Ref: IA-G0004-x Summary DCC Vital welcomes the new draft guidance which will provide clarity
More informationIntroduction to the new regulatory framework for medical devices and in vitro diagnostic medical devices
Introduction to the new regulatory framework for medical devices and in vitro diagnostic medical devices Vincent Houdry DG for Internal Market, Industry, Entrepreneurship and SMEs European Commission Key
More informationThe European Medical Technology Industry. in figures / 2018
The European Medical Technology Industry in figures / 2018 Table of contents What is Medical Technology? 4 Innovation 10 Employment 14 Companies 18 Expenditure on Medical Technology 20 MedTech Market in
More informationPROPOSED DOCUMENT. International Medical Device Regulators Forum. Title: Common Data Elements for Medical Device Identification
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 PROPOSED DOCUMENT International Medical Device Regulators Forum Title: Common Data Elements for Medical Device Identification
More informationJapan Update - Implementation of PMD Act - March, 2015
Japan Update - Implementation of PMD Act - March, 2015 Topics Implementation of PMD Act; Revision of Pharmaceutical Affairs Law (PAL) PMDA Medical Device Training Seminar 2 Implementation of PMD Act: The
More informationAWS Glossary of Terms
AWS Glossary of Terms Version 1.0 July, 2015 2015 Alliance for Water Stewardship Inc. Purpose The purpose of this document is to define the terms, abbreviations and acronyms used by AWS. Responsibility
More informationComparison of tasks and responsibilities in the building control systems of European Union countries
Comparison of tasks and responsibilities in the building control systems of European Union countries João Branco Pedro 1&2, Frits Meijer 1 and Henk Visscher 1 1 OTB Research Institute for Housing, Urban
More informationU.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical Devices
Lisa L. Michels General Counsel & Regulatory Expert Susan J. Schniepp, Distinguished Fellow Regulatory Compliance Associates Inc. U.S. Food and Drug Administration (FDA) Regulatory Pathways for Medical
More informationExperience with Directive 93/42/EEC (MDD)
(MDD) A medical device manufacturer s retrospective view on 19 years of experience with Directive 93/42/EEC Lübeck, 2012-09-05, Dr. Peter Gebhardt Preliminary Remarks Scope of this presentation is based
More informationNews of the MDR and IVDR with a focus on innovation, UDI coding and traceability. Roberto Belliato
News of the MDR and IVDR with a focus on innovation, UDI coding and traceability. Roberto Belliato 26 september 2018 Taking in account that main changes stated by the IVD/MDR Regulation concern Manufacturers
More informationASIA REGULATORY REVIEW QUARTERLY UPDATE. Second Quarter, June
ASIA REGULATORY REVIEW QUARTERLY UPDATE Second Quarter, June 2013 1 NEW DEVELOPMENTS... 2 CHINA... 2 HONG KONG... 3 INDIA... 3 INDONESIA... 4 JAPAN... 4 MALAYSIA... 5 SINGAPORE... 5 SOUTH KOREA... 5 TAIWAN...
More informationMedical Device Single Audit Program (MDSAP) An Overview Canadian Experience
Medical Device Single Audit Program (MDSAP) An Overview Canadian Experience Linda Chatwin Sr. Customer Solutions Consultant : 360-817-5556 : linda.chatwin@ul.com LINDA M CHATWIN, Esq, RAC Biography Ms.
More informationCode of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products
Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products March 2014 Table of Content INTRODUCTION 3 Section 1: GENERAL RESPONSIBILITIES OF HOLDER
More informationMed-Info. Introduction to Korean medical device regulations. TÜV SÜD Product Service GmbH
Med-Info International expert information for the medical device industry Introduction to Korean medical device regulations The Ministry of Food and Drug Safety (MFDS) is the healthcare agency having overall
More informationThird WHO Global Forum on Medical Devices. South East Asia Regional Perspective
Third WHO Global Forum on Medical Devices South East Asia Regional Perspective Medical device regulatory systems in SEAR National medicines policies exists in most countries and some of these also cover
More informationUNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS
UNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS Executive Summary European Medicines Agency (EMA) regulations for licensing of medical devices include the use of authorized
More informationIMPLEMENTATION OF THE HONG KONG VOLUNTARY ENERGY EFFICIENCY LABELLING SCHEME
IMPLEMENTATION OF THE HONG KONG VOLUNTARY ENERGY EFFICIENCY LABELLING SCHEME Lam Kam-Kuen Electrical and Mechanical Services Department, Energy Efficiency Office Government of the Hong Kong Special Administrative
More informationQUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION
PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction
More informationEnvironment Agencies Statement on Radioactive Waste Advisers
Environment Agencies Statement on Radioactive Waste Advisers Document Ref: RWA-S-1 Version 1.0 Publication date: 24 May 2011 Contents 1 Executive Summary... 3 2 Introduction... 4 3 Background... 4 3.1
More informationPROPOSED FINAL DOCUMENT
AHWP/WG1a/PF004:2013 PROPOSED FINAL DOCUMENT Title: Author: Comparison between the GHTF Summary Technical Documentation (STED) formats for Medical Devices and In Vitro Diagnostic Medical Devices and the
More information